Viraferonpeg and weight decreased Patient Reports March 21, 2010



Viraferonpeg Side Effects Report #5076041-0
Viraferonpeg side effect was reported by a Consumer or non-health professional from FRANCE on July 26, 2006. Male patient, 68 years of age, weighting 121.3 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: hepatic neoplasm malignant, sarcoma, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5403460-2
Viraferonpeg side effect was reported by a Pharmacist from FRANCE on July 23, 2007. Male patient, 65 years of age, weighting 154.3 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: ageusia, asthenia, depression What is  depression, fatigue, hyperaesthesia, hyperhidrosis, myalgia, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, SOTALOL HYDROCHLORIDE, AMLODIPINE, RENITEC, KARDEGIC. Patient recovered.

Viraferonpeg Side Effects Report #5863861-5
Viraferonpeg side effect was reported by a Physician from FRANCE on Aug 21, 2008. Female patient, 65 years of age, weighting 163.1 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: asthenia, prothrombin level decreased, pulmonary embolism What is  pulmonary embolism, weight decreased. Viraferonpeg dosage: unknown. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5875886-4
Viraferonpeg side effect was reported by a Physician from FRANCE on Aug 29, 2008. Female patient, 65 years of age, weighting 163.1 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: asthenia, cough, pulmonary embolism What is  pulmonary embolism, weight decreased. Viraferonpeg dosage: unknown. Patient was hospitalized. Patient recovered.


Viraferonpeg Side Effects Report #5878625-6
Viraferonpeg side effect was reported by a Physician from FRANCE on Sept 05, 2008. Female patient, 65 years of age, weighting 163.1 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: asthenia, prothrombin level decreased, pulmonary embolism What is  pulmonary embolism, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5134279-8
Viraferonpeg side effect was reported by a Physician from FRANCE on Sept 25, 2006. Female patient, 56 years of age, weighting 143.3 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: diabetes mellitus, glycosylated haemoglobin increased, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #4815144-X
Viraferonpeg side effect was reported by a Physician from FRANCE on Oct 19, 2005. Female patient, 56 years of age, weighting 136.7 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: asthenia, muscle atrophy, myalgia, pyrexia, tooth loss, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, DETENSIEL, HYZAAR, LEVOTHYROX, GIKOR, RIVOTRIL. Patient recovered.

Viraferonpeg Side Effects Report #5768756-3
Viraferonpeg side effect was reported by a Consumer or non-health professional from FRANCE on June 06, 2008. Female patient, 55 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: arthralgia, asthenia, depression What is  depression, musculoskeletal pain, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5199528-9
Viraferonpeg side effect was reported by a Physician from FRANCE on Dec 20, 2006. Female patient, 53 years of age, weighting 119.0 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: blood thyroid stimulating hormone decreased, malignant melanoma, papillary thyroid cancer, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, TEGRETOL, VALSARTAN AND HYDROCHLOROTHIAZIDE, MEDIATENSYL, DIPENTUM. Patient recovered.


Viraferonpeg Side Effects Report #5323663-5
Viraferonpeg side effect was reported by a Physician from UNITED KINGDOM on Apr 24, 2007. Female patient, 50 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: depression What is  depression, hepatic fibrosis, platelet count decreased, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient recovered.

Viraferonpeg Side Effects Report #5176425-6
Viraferonpeg side effect was reported by a Physician from FRANCE on Nov 29, 2006. Male patient, 45 years of age, weighting 172.0 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: cardiogenic shock, congestive cardiomyopathy, fatigue, inflammation, pleural effusion, pulmonary hypertension What is  pulmonary hypertension, viral infection What is  viral infection, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient died on 12/01/2003.

Viraferonpeg Side Effects Report #4758506-1
Viraferonpeg side effect was reported by a Physician from FRANCE on Aug 19, 2005. Male patient, 40 years of age, weighting 180.8 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: arthralgia, pericarditis, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized and became disabled. Patient recovered.

Viraferonpeg Side Effects Report #4696778-2
Viraferonpeg side effect was reported by a Physician from on June 10, 2005. Male patient, 30 years of age, weighting 194.0 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: arthralgia, pericarditis, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5832465-2
Viraferonpeg side effect was reported by a Pharmacist from FRANCE on July 28, 2008. Male patient was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: delirium, delusion, hyperhidrosis, pyrexia, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, SUBUTEX, MYCOSTATINE, IMOVANE, SERTRALINE, ARIPIPRAZOLE, ZYPREXA, ATARAX. Patient was hospitalized. Patient recovered.


Viraferonpeg Side Effects Report #5863865-2
Viraferonpeg side effect was reported by a Physician from FRANCE on Aug 22, 2008. Male patient, 52 years of age, was diagnosed with hepatitis b What is  hepatitis b and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: leukopenia, muscle disorder What is  muscle disorder, myalgia, neutrophil count decreased, polyneuropathy, thrombocytopenia, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with PEGASYS. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Viraferonpeg